Similarly, Substance P participates in the regulation of glucose metabolism via insulin signaling-associated pathways, and in rats its intravenous administration leads to hypoinsulinemia, hyperglucagonemia, and subsequently to hyperglycemia (128, 129). Here, INS is linked to Hyperglycemia.